Eye on Relief: Pharmacist-Driven Care in Allergic Conjunctivitis (Pharmacy Technician Credit)

Program Description

Seasonal allergic conjunctivitis (SAC) and perennial allergic conjunctivitis (PAC) are IgE-mediated inflammatory reactions often triggered by allergens. While the clinical presentation is largely similar between the two conditions, SAC is often caused by outdoor allergens such as pollen and PAC may be triggered by indoor allergens such as house dust mites or animal dander. Pharmacists play a critical role in therapy selection for SAC and PAC because the medication landscape includes numerous OTC and prescription options with distinct mechanisms, onset times, and durations of action that must be matched to each patient's specific allergen exposure pattern and symptom severity. Understanding the nuances of OTC and prescription therapies for allergic conjunctivitis enables pharmacists to optimize therapy selection, counsel on proper administration, monitor for adverse effects, and identify patients requiring ophthalmology referral for refractory symptoms. This article also features multimedia elements designed to support evidence-based counseling approaches on OTC and prescription products for the treatment of allergic conjunctivitis.

Target audience: Pharmacy technicians
Type of activity: Application
Release date: June 26, 2026
Expiration date: June 26, 2027
Learner level: Foundational, Intermediate
Time to complete activity: 2.0 hour
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Examine the clinical presentation of allergic conjunctivitis as well as signs and symptoms of a more complex presentation that warrants pharmacist or eye specialist intervention
• Identify the roles and responsibilities of both pharmacists and pharmacy technicians in improving patient access to safe, appropriate, and cost-effective treatment options for allergic conjunctivitis
• Explore the ways pharmacy technicians support pharmacist-directed management of allergic conjunctivitis, including over-the-counter product selection assistance, reinforcement of proper ophthalmic administration techniques, and patient education on nonpharmacologic strategies

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours (0.20 CEU) under the ACPE universal activity number 0290-0000-26-183-H01-T. The activity is available for CE credit through June 26, 2027.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, view the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Faculty

The following contributors have no relevant financial relationships with ineligible companies to disclose:

Faculty

Madison Silvestri, PharmD, MPH; Sarah J. Yu, PharmD; Rupal Mansukhani, PharmD, CTTS, FAPhA

Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Dipti Desai, PharmD, MBA, CHCP;Macara Desai; Susan Pordon; Brianna Winters; and Chloe Taccetta

Pharmacy Times® Editorial Staff— Aislinn Antrim

Any relevant financial relationships listed for these individuals have been mitigated.

At least one anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with ineligible companies to disclose.

Educational Disclaimer

Continuing professional education activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved by the labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
ceinfo@pharmacytimes.com
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms